GCM
IMCR icon

Graham Capital Management’s Immunocore IMCR Stock Holding History

Graham Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,703
Closed -$337K – 1338
2025
Q4 		$337K Sell
9,703
-3,422
-26% -$121K 0.01% 806
2025
Q3 		$477K Sell
13,125
-1,571
-11% -$53.4K 0.01% 633
2025
Q2 		$461K Buy
+14,696
New +$457K 0.01% 859
2024
Q4 		– Sell
-11,345
Closed -$353K – 1349
2024
Q3 		$353K Buy
11,345
+5,087
+81% +$185K 0.01% 735
2024
Q2 		$212K Buy
6,258
+1,953
+45% +$99.6K ﹤0.01% 847
2024
Q1 		$280K Buy
+4,305
New +$295K 0.01% 811
2023
Q4 		– Sell
-7,914
Closed -$411K – 1147
2023
Q3 		$411K Buy
+7,914
New +$468K 0.01% 619

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Graham Capital Management's IMCR Position: Q1 2026 in Review

Graham Capital Management sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 9,703 shares — an estimated $337K sold.

Graham Capital Management first reported a position in IMCR in Q3 2023 and held it in 7 quarters. The position peaked at $477K in Q3 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Graham Capital Management reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 9,703 Immunocore shares in Q1 2026, an estimated $337K.
  • Graham Capital Management first reported a position in Immunocore in Q3 2023 and held it in 7 quarters.
  • Graham Capital Management's Immunocore position peaked at $477K in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.